← Leaderboards
Christopher K Arnatt
Saint Louis University
$1,774,864
Attributed
$4,947,155
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2019–25$2M$1.5M$1M$500K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,947,155 · 3
By mechanism
R01$3,435,185 · 2
R61$1,511,970 · 1
Top collaborators
- Benjamin J. Bythell4 shared
- James L Edwards4 shared
- Gary J Patti4 shared
- Daniela Salvemini4 shared
- John K. Walker1 shared
Most similar at Saint Louis University
Same institution · by research overlap
- James L Edwards$1,204,218
- Benjamin J. Bythell$446,718
- Willis K. Samson$5,496,072
- Aubin Moutal$1,617,986
- Gina L.c. Yosten$4,545,643
Others in their field
Other Emerging Leaders on “Injections”
- Yunda Huang · Fred Hutchinson Cancer Center$58,397,458
- Xinhua Li · Nano Terra, Inc.$35,520,438
- Laura McNay · Leidos Biomedical Research, Inc.$15,147,252
- Manish Ishwar Shah · Baylor College Of Medicine$13,280,421
- Benjamin E Deverman · Broad Institute, Inc.$12,739,936
- Nikej Shah · Nirsum Laboratories, Inc.$12,506,430
Research focus
InjectionsSignal TransductionResponseVertebral ColumnStructureBaseBindingCostCardiacCoupledAffinityCarbonCationsClutteringsBioinformatics ToolAnalogCellsBehavioral PhenotypingBehavioral ResponseBehavioral StudyAntagonistBehavioralBiochemicalAnalgesics
Grant awards (8)
Uncovering the roles of oxysterols in neuropathic pain$545,271
R01 · FY2025 · NS
Development of selective GPR34 antagonists for the treatment of neuropathic pain$1,511,970
R61 · FY2024 · NS
Uncovering the roles of oxysterols in neuropathic pain$582,767
R01 · FY2023 · NS
Uncovering the roles of oxysterols in neuropathic pain$520,274
R01 · FY2022 · NS
Universal Metabolite Tagging$440,364
R01 · FY2022 · GM
Universal Metabolite Tagging$440,364
R01 · FY2021 · GM
Universal Metabolite Tagging$440,364
R01 · FY2020 · GM
Universal Metabolite Tagging$465,781
R01 · FY2019 · GM